Summary
Bilateral or unilateral cochlear implantation with an FDA-approved device may be considered medically necessary in individuals aged 7 months and older with bilateral severe-to-profound pre- or post-lingual sensorineural hearing loss (pure-tone average of 70 dB or greater at 500, 1000 and 2000 Hz) who have shown limited or no benefit from hearing aids. The age requirement was revised from 9 months to 7 months in the 08/03/2026 update. Cochlear implantation as a treatment for unilateral hearing loss with or without tinnitus is considered investigational.
Get alerts when payers change rules like this one
We check Blue Cross & Blue Shield of Mississippi and other payers every day and email you when a change matches your specialty and state.